Paxman AB (publ) (STO:PAX)

Sweden flag Sweden · Delayed Price · Currency is SEK
57.00
+1.00 (1.79%)
Dec 5, 2025, 5:29 PM CET
-21.92%
Market Cap 1.30B
Revenue (ttm) 305.02M
Net Income (ttm) 4.77M
Shares Out 23.27M
EPS (ttm) 0.23
PE Ratio 238.60
Forward PE 42.50
Dividend n/a
Ex-Dividend Date n/a
Volume 107,554
Average Volume 55,688
Open 56.00
Previous Close 56.00
Day's Range 55.60 - 58.20
52-Week Range 50.60 - 85.80
Beta 0.47
RSI 39.36
Earnings Date Nov 14, 2025

About Paxman AB

Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to develop a wearable medical cooling device; and the National University Hospital of Singapore for the development of a cooling and compression system. Paxman AB (publ) was founded in 1996 and is headquartered in Karlshamn, Sweden. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1996
Employees 105
Stock Exchange Nasdaq Stockholm
Ticker Symbol PAX
Full Company Profile

Financial Performance

In 2024, Paxman AB's revenue was 263.20 million, an increase of 19.30% compared to the previous year's 220.61 million. Earnings were 40.20 million, an increase of 382.55%.

Financial Statements

News

There is no news available yet.